Los Angeles Mesothelioma Lawyer Directory
Friday, June 26, 2015
E2F4 signature can predict progression of bladder cancer
Investigators harnessed genomic data to discover that the previously identified E2F4 signature in breast cancer can be utilized to predict prognosis and response to therapy in bladder cancer.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment